CULVER CITY, Calif., February 19, 2025--ImmunityBio, Inc. (NASDAQ: IBRX), a leading immunotherapy company, today announced the U.S. Food and Drug Administration (FDA) has authorized an expanded ...

Merck’s TICE BCG has been the lone BCG product in the U.S. since 2012, coming after Sanofi and another drugmaker ran into manufacturing problems. Sanofi officially pulled out of the market in 2016.

A clinical trial with long-term follow-up found that administering BCG vaccine during the active phase of COVID-19 appeared to offer protection against long COVID symptoms.

TICE BCG prescription and dosage information for physicians and health care professionals. Pharmacology, adverse reactions, warnings, and TICE BCGside effects.

The following is a statement from biopharmaceutical company Merck regarding a global shortage of BCG, a medication used in the treatment of bladder cancer:Since 2012, when Merck unexpectedly ...